21st Mar 2019
New York, US
Cell and gene investor day

ARM’s 7th Annual Cell & Gene Therapy Investor Day is a one-day meeting providing institutional, strategic and venture investors with unique insight into financing opportunities for cell and gene therapy-based treatment and tools. David Venables will be presenting at 11.25am in the Main Bar Room if you would like to find out more about Synpromics' novel synthetic promoter technology.